SU1056900A3 - Способ получени пиримидинонов или их кислотно-аддитивных солей - Google Patents

Способ получени пиримидинонов или их кислотно-аддитивных солей Download PDF

Info

Publication number
SU1056900A3
SU1056900A3 SU813354550A SU3354550A SU1056900A3 SU 1056900 A3 SU1056900 A3 SU 1056900A3 SU 813354550 A SU813354550 A SU 813354550A SU 3354550 A SU3354550 A SU 3354550A SU 1056900 A3 SU1056900 A3 SU 1056900A3
Authority
SU
USSR - Soviet Union
Prior art keywords
carbon atoms
group
phenyl
substituted
methyl
Prior art date
Application number
SU813354550A
Other languages
English (en)
Russian (ru)
Inventor
Гейдер Иоахим
Аустель Фолькхард
Эберлейн Вольфганг
Кадатц Рудольф
Лиллие Кристиан
Original Assignee
Др.Карл Томэ Гмбх (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803046871 external-priority patent/DE3046871A1/de
Priority claimed from DE19813115447 external-priority patent/DE3115447A1/de
Application filed by Др.Карл Томэ Гмбх (Фирма) filed Critical Др.Карл Томэ Гмбх (Фирма)
Application granted granted Critical
Publication of SU1056900A3 publication Critical patent/SU1056900A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
SU813354550A 1980-12-12 1981-11-18 Способ получени пиримидинонов или их кислотно-аддитивных солей SU1056900A3 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803046871 DE3046871A1 (de) 1980-12-12 1980-12-12 Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
DE19813115447 DE3115447A1 (de) 1981-04-16 1981-04-16 Neue pyrimidinone, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
SU1056900A3 true SU1056900A3 (ru) 1983-11-23

Family

ID=25789685

Family Applications (1)

Application Number Title Priority Date Filing Date
SU813354550A SU1056900A3 (ru) 1980-12-12 1981-11-18 Способ получени пиримидинонов или их кислотно-аддитивных солей

Country Status (22)

Country Link
US (1) US4379788A (cg-RX-API-DMAC10.html)
EP (1) EP0054132B1 (cg-RX-API-DMAC10.html)
AR (1) AR227567A1 (cg-RX-API-DMAC10.html)
AU (1) AU543568B2 (cg-RX-API-DMAC10.html)
CA (1) CA1217767A (cg-RX-API-DMAC10.html)
CS (1) CS227024B2 (cg-RX-API-DMAC10.html)
DD (1) DD208151A5 (cg-RX-API-DMAC10.html)
DE (1) DE3166627D1 (cg-RX-API-DMAC10.html)
DK (1) DK525481A (cg-RX-API-DMAC10.html)
ES (2) ES8207156A1 (cg-RX-API-DMAC10.html)
FI (1) FI813971A7 (cg-RX-API-DMAC10.html)
GB (1) GB2090249B (cg-RX-API-DMAC10.html)
GR (1) GR76952B (cg-RX-API-DMAC10.html)
HU (1) HU187384B (cg-RX-API-DMAC10.html)
IL (1) IL64504A (cg-RX-API-DMAC10.html)
MY (1) MY8700562A (cg-RX-API-DMAC10.html)
NO (1) NO814239L (cg-RX-API-DMAC10.html)
NZ (1) NZ199254A (cg-RX-API-DMAC10.html)
PH (1) PH18930A (cg-RX-API-DMAC10.html)
PL (1) PL135330B1 (cg-RX-API-DMAC10.html)
PT (1) PT74116B (cg-RX-API-DMAC10.html)
SU (1) SU1056900A3 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029389A1 (en) * 1998-11-18 2000-05-25 Elena Alexandrovna Izaxon 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity
RU2650107C2 (ru) * 2012-09-26 2018-04-09 Мерк Патент Гмбх Производные хиназолинона в качестве ингибиторов parp

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460589A (en) * 1980-10-03 1984-07-17 The Upjohn Company Process for treating hypertension
US4379778A (en) * 1980-10-10 1983-04-12 Air Products And Chemicals, Inc. Hydrogen peroxide synthesis
DE3428476A1 (de) * 1984-08-02 1986-02-13 Basf Ag, 6700 Ludwigshafen 4h-pyrido(2,3-d)(1,3)oxazin-4-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
DE3631294A1 (de) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K Neue synergistische kombination bestehend aus einem phosphodiesterase-hemmer und einem thromboxan-a(pfeil abwaerts)2(pfeil abwaerts)-antagonisten und deren verwendung bzw. herstellung
US5037980A (en) * 1988-04-18 1991-08-06 American Cyanamid Company Phenyl imidazo[1,2-a]pyrimidines
GB8928346D0 (en) * 1989-12-15 1990-02-21 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
CA2309332C (en) * 1997-11-12 2002-12-03 Bayer Aktiengesellschaft 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
US20040102324A1 (en) 2002-02-28 2004-05-27 Annis Gary David Heterocyclic diamide invertebrate pest control agents
US6642244B2 (en) 2001-03-16 2003-11-04 Bristol-Myers Squibb Co. Pyrazolopyridopyrimidine inhibitors of cGMP phosphodiesterase
CA2444704C (en) * 2001-04-23 2012-07-10 University Of Virginia Patent Foundation Synthesis and evaluation of phthalimide mimics as anti-angiogenic agents
MXPA03010119A (es) * 2001-05-09 2005-03-07 Bayer Healthcare Ag Nuevo uso de imidazotriazinonas 2-fenilo sustituidas.
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
EP1696927A4 (en) * 2003-12-19 2007-10-31 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
SE0401342D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds
SE0401345D0 (sv) * 2004-05-25 2004-05-25 Astrazeneca Ab Therapeutic compounds: Pyridine as scaffold
AU2005247808B2 (en) * 2004-05-31 2011-02-10 Msd K.K. Quinazoline derivative
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
SG166106A1 (en) * 2005-09-29 2010-11-29 Bayer Schering Pharma Ag Pde inhibitors and combinations thereof for the treatment of urological disorders
AU2007303846B2 (en) * 2006-10-04 2011-03-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as calcium receptor antagonists
KR20100029762A (ko) * 2007-06-13 2010-03-17 바이엘 쉐링 파마 악티엔게젤샤프트 청력 장애 치료용 ｐｄｅ 억제제
CN101531638B (zh) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用
CN102098918A (zh) * 2008-05-13 2011-06-15 帕纳德制药公司 用于治疗癌症和神经退行性疾病的生物活性化合物
CN101628913B (zh) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265697A (en) * 1964-09-04 1966-08-09 Shulton Inc 2-p-dialkylaminoalkoxyphenyl-2, 3-dihydro-4 (1h)-quinazolinones and their derivatives
DE1939109A1 (de) * 1968-08-31 1970-03-05 Troponwerke Dinklage & Co 2-Methyl-3-[2-(2-diaethylaminoaethoxy)-phenyl]-chinazolinon-(4) und Verfahren zu seiner Herstellung
US3862191A (en) * 1972-09-27 1975-01-21 Pfizer Pyrido{8 2,3-d{9 pyrimidin-4(3H)-one

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Бюлер К., Пирсон Д. Органические синтезы. Ч.1, М., Мир, 1973. .с. 505, 518. 2. За вка DE № 2643384, кл. С 07 D 239/70, опублик. 1977. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000029389A1 (en) * 1998-11-18 2000-05-25 Elena Alexandrovna Izaxon 6-(3-carboxymethylphenyl)-aminouracyl having a biological activity
RU2650107C2 (ru) * 2012-09-26 2018-04-09 Мерк Патент Гмбх Производные хиназолинона в качестве ингибиторов parp

Also Published As

Publication number Publication date
ES511835A0 (es) 1983-02-16
GB2090249A (en) 1982-07-07
MY8700562A (en) 1987-12-31
PT74116A (de) 1982-01-01
ES8304096A1 (es) 1983-02-16
HU187384B (en) 1985-12-28
ES507761A0 (es) 1982-09-01
GB2090249B (en) 1984-08-22
PL234175A1 (cg-RX-API-DMAC10.html) 1982-08-16
DD208151A5 (de) 1984-03-28
EP0054132A1 (de) 1982-06-23
EP0054132B1 (de) 1984-10-10
FI813971L (fi) 1982-06-13
CS227024B2 (en) 1984-04-16
NZ199254A (en) 1985-02-28
DE3166627D1 (en) 1984-11-15
IL64504A (en) 1985-02-28
AR227567A1 (es) 1982-11-15
NO814239L (no) 1982-06-14
AU7847381A (en) 1982-06-17
AU543568B2 (en) 1985-04-26
GR76952B (cg-RX-API-DMAC10.html) 1984-09-04
IL64504A0 (en) 1982-03-31
DK525481A (da) 1982-06-13
PT74116B (de) 1983-12-19
ES8207156A1 (es) 1982-09-01
PL135330B1 (en) 1985-10-31
FI813971A7 (fi) 1982-06-13
PH18930A (en) 1985-11-11
US4379788A (en) 1983-04-12
CA1217767A (en) 1987-02-10

Similar Documents

Publication Publication Date Title
SU1056900A3 (ru) Способ получени пиримидинонов или их кислотно-аддитивных солей
EP0107398B1 (en) Ortho substituted dihydroxy-2(1h)quinazolinone-1-alkanoic acids
CZ293482B6 (cs) DihydropyrimidinyŹ způsob jejich výrobyŹ léčiva tyto látky obsahující a jejich použití
CA1066282A (en) .beta.-ADRENERGIC RECEPTOR BLOCKING AGENTS
CH655110A5 (de) Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
EP0619808B1 (en) 3-hydroxypyridin-4-one derivatives as chelating agents
US4672116A (en) Substituted 5,6-dialkoxyquinazoline derivatives
EP0031885A1 (de) Basische Äther, diese enthaltende pharmazeutische Zubereitungen und Verfahren zu ihrer Herstellung
FI95250C (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten kromaanijohdannaisten valmistamiseksi
JPS6248669A (ja) フエニルキノリン誘導体、その製造法および医薬組成物
GB1568021A (en) Isoquinoline and naphthyridine substituted aminoalkoxphenol derivatives
DD145104B3 (de) Verfahren zur herstellung von polyalkoxyphenylpyrrolidone
EP1611126B1 (de) Chromenonindole
DE3049959C2 (cg-RX-API-DMAC10.html)
SK279095B6 (sk) Deriváty chrómanu samy osebe a na liečenie chorôb,
US3753994A (en) 1,1'-azinobis(1,2,3,4-tetrahydroisoquinolines)
DE10331500A1 (de) Neue Acridin-Derivate und deren Verwendung als Arzneimittel
US4055650A (en) Certain 4-phenoxy(or phenylthio)-3-n-acylated-sulfonamido-pyridines
DE3046871A1 (de) Neue chinazolinone, ihre herstellung und ihre verwendung als arzneimittel
US4517365A (en) Isocarbostyril derivative
US12391707B2 (en) Preparation method for oxazepine compound
DE102006029795A1 (de) Neue Harnstoff-Derivate und deren Verwendungen
US4596830A (en) Novel derivatives of 2-(2-thienyl)-imidazo[4,5-b]-pyridines and their pharmaceutically acceptable salts
AU2019218150B2 (en) Crystal form of 3,4-dihydrothieno[3,2-d]pyrimidine compound and preparation method therefor
US5162533A (en) 3-cyano-5,4'-bipyridine-1'-oxide compounds and pharmaceutical compositions and methods containing the same